All Type of News
60 drug makers to penalize on charge of direct sales to hospitals.
It was found that more than 900 drugs were directly sold by drug makers to hospitals, which is illegal and therefore subjected to penalize possibly ranged from the business suspension and fine. The KFDA said on April ...
KFDA to establish D/B for drug registration.
The KFDA already undertook an establishment of DB for the drug registration, which may provide more accurate and credible drug informations in the future.
The project was purported for the information services of d...
689 hospitals to charge on unfair bills last year.
The total 689 medical institutions billed false charges last year in the amount to 8.9 billion won, showing 13 million won per an institution on average.
The MOHW disclosed the above status on April 4 after investi...
Roche/Sanofi on joint multinational clinical studies for cancer drugs.
The phase III clinical study called CLASSIC (Capecitabine and OxaLiplatin Adjuvant Study in Stomach Cancer) for an adjuvant cancer therapy after the stomach surgical operation may be jointly conducted by Roche Korea a...
National Assembly to curb government's KFDA split move.
The government movement for the current KFDA to split into the Food Safety Agency and the Drug Safety Division affiliated to the MOHW seems to be curbed at the National Assembly.
A strong opposition has been surfa...
KMA/KPA in serious conflict on idle stocks.
The KMA and KPA seem to face inevitable confrontations over how to resolve the mounting problems of idel drug stocks.
President Won Hee-mok of the KPA expressed a positive attitude over the public hearing as raised...
New drugs developed by local companies not successful on markets.
The 11th new drug developed by a local drug company may be introduced soon but the marketability of those new drugs has not made any progress at all. 7 in 10 new drugs in Korea showed less than 2 billion won of an...
Bio-equivalency test for 60 ingredients including Cefaclor mandatory.
Of the drug ingredients that were not proven of its bio-equivalency, the KFDA designated 60 ingredients including Cefaclor to be verified mandatorily.
The KFDA announced the detailed bio equivalency reviews before ...
Daewoong to reinforce anticancer drug business.
In strategic alliance with Reyon Pharm. for the anti-cancer and immunity suppressant drug business, Daewoong has agreed an MOU to reinforce the anti-cancer drug business in the future.
Reyon Pharm has developed a l...
Yuhan to reorganize for more marketing and customer services.
Yuhan has reorganized the company more for the marketing specialization and customer service reinforcement.
The hospital marketing team was divided into ETC marketing I and II and the PL team was newly established...
